PACS
PACS
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
9
$35.78M
Total Volume
$35.78M
28 transactions
Net Activity
$35.78M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale Insiders
$380.29M total
Murray Jason Hulse
Co-Founder, CEO, COB, 10%
$23.32M total
Hancock Mark
Dir, 10%
$10.08M total
Jergensen Joshua
Pres, COO
$1.78M total
Lewis Michelle Renee
Chief Accounting Officer
$593K total
Quick Actions
PACS has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. PACS ranks #85 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at PACS (PACS) engaged in a total of 28 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 9 were sales. The total volume of insider trading reached $35.78M.
The net insider activity for PACS shows a net selling bias of $35.78M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 22.7K shares valued at $380.29M on Nov 24, 2025.
PACS Group, Inc. (PACS) stock price, news, quote and history
PACS Group, Inc. (PACS) stock price, news, quote and history
PACS Group, Inc. (PACS) Stock Price, News, Quote & History
PACS: Raised 2026 EBITDA outlook and 78 new facilities underpin continued growth
Will Raised Revenue Guidance Change PACS Group (PACS) Stock Narrative
Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
FAQs About PACS Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for PACS.